To this point, evaluation of the anticancer activity of methuosis-inducing compounds has become confined predominantly to mobile society techniques. Having said that, two new reports have highlighted the opportunity for exploiting this novel kind of cell Loss of life for treating cancers in vivo. In a single examine Huang et al. [fifteen] recognize